Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,044 | 30,360 | 24,923 | 59,273 | 70,364 |
| Marketable Securities | 23,956 | 48,994 | 77,959 | 58,091 | 34,164 |
| Receivables | 1,006 | 3,313 | 1,555 | 1,988 | 1,366 |
| TOTAL | $116,520 | $89,510 | $107,972 | $121,345 | $108,275 |
| Non-Current Assets | |||||
| PPE Net | 382 | 433 | 439 | 481 | 296 |
| Investments And Advances | 0 | 2,543 | 1,171 | 0 | 0 |
| Other Non-Current Assets | 2,174 | 2,360 | 2,222 | 1,858 | 1,992 |
| TOTAL | $2,556 | $5,336 | $3,832 | $2,339 | $2,288 |
| Total Assets | $119,076 | $94,846 | $111,804 | $123,684 | $110,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,956 | 5,931 | 4,244 | 1,499 | 1,316 |
| Accrued Expenses | 2,232 | 2,476 | 2,543 | 1,778 | 1,268 |
| TOTAL | $14,181 | $17,796 | $16,820 | $13,664 | $11,853 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,332 | 1,983 | 764 | 330 | N/A |
| Other Non-Current Liabilities | 806 | 981 | 925 | 1,059 | 1,191 |
| TOTAL | $806 | $981 | $925 | $1,059 | $1,191 |
| Total Liabilities | $14,987 | $18,777 | $17,745 | $14,723 | $13,044 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,091 | 2,090 | 1,474 | 1,472 | 1,163 |
| Common Shares | 31 | 22 | 22 | 22 | 17 |
| Retained earnings | -337,199 | -314,761 | -295,854 | -279,821 | -262,573 |
| Other shareholders' equity | 5 | 5 | 8 | 41 | 140 |
| TOTAL | $104,089 | $76,069 | $94,059 | $108,961 | $97,519 |
| Total Liabilities And Equity | $119,076 | $94,846 | $111,804 | $123,684 | $110,563 |